11:59 AM
 | 
Feb 15, 2019
 |  BC Week In Review  |  Company News  |  Other News

PTAB to review Biogen's Tecfidera patent

The U.S. Patent Trial and Appeal Board will review a patent held by Biogen Inc. (NASDAQ:BIIB) covering methods of treating multiple sclerosis with...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >